2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide
C29H35FN4O2 — CID 91142455
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide
2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide (PubChem CID 91142455) has the molecular formula C29H35FN4O2 and a molecular weight of 490.62 g/mol. Its IUPAC name is 2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide.
Molecular Properties
| Compound Name | 2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide |
|---|---|
| PubChem CID | 91142455 |
| Molecular Formula | C29H35FN4O2 |
| Molecular Weight | 490.62 g/mol |
| Exact Mass | 490.27 |
| IUPAC Name | 2-[4-[2-amino-3-(4-fluorophenyl)propanoyl]-3-ethylpiperazin-1-yl]-3-naphthalen-2-ylbutanamide |
| SMILES | CCC1CN(C(C(N)=O)C(C)c2ccc3ccccc3c2)CCN1C(=O)C(N)Cc1ccc(F)cc1 |
| InChI | InChI=1S/C29H35FN4O2/c1-3-25-18-33(14-15-34(25)29(36)26(31)16-20-8-12-24(30)13-9-20)27(28(32)35)19(2)22-11-10-21-6-4-5-7-23(21)17-22/h4-13,17,19,25-27H,3,14-16,18,31H2,1-2H3,(H2,32,35) |
| InChIKey | JUGOAQFZUHPZLN-UHFFFAOYSA-N |
| XLogP | 3.43 |
| TPSA | 92.66 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 490.62 |
| LogP ≤ 5 | 3.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91142455 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.